Literature DB >> 22127590

Uncommon late relapse of angioimmunoblastic T-cell lymphoma after 16-year remission period.

Edit Páyer1, Zsófia Miltényi, Zsófia Simon, Lajos Szabados, Katalin Hegyi, Gábor Méhes, Arpád Illés.   

Abstract

Entities:  

Mesh：

Year:  2011        PMID： 22127590     DOI： 10.1007/s12253-011-9475-7

Source DB:  PubMed          Journal:  Pathol Oncol Res        ISSN： 1219-4956            Impact factor:   3.201


× No keyword cloud information.
  35 in total

Review 1.  Angioimmunoblastic T-cell lymphoma.

Authors:  Ahmet Dogan; Ayoma D Attygalle; Chara Kyriakou
Journal:  Br J Haematol       Date:  2003-06       Impact factor: 6.998

2.  Increased serum levels of soluble IL-2 receptor, CD30 and CD8 molecules, and gamma-interferon in angioimmunoblastic lymphadenopathy: possible pathogenetic role of immunoactivation mechanisms.

Authors:  G Pizzolo; H Stein; O Josimovic-Alasevic; F Vinante; R Zanotti; M Chilosi; A C Feller; T Diamantstein
Journal:  Br J Haematol       Date:  1990-08       Impact factor: 6.998

Review 3.  Angioimmunoblastic lymphadenopathy with dysproteinemia.

Authors:  C E Freter; J Cossman
Journal:  Semin Oncol       Date:  1993-12       Impact factor: 4.929

4.  Cytoplasmic cytokines in lymphoproliferative disorders: multiple cytokine production in angioimmunoblastic lymphadenopathy with dysproteinemia.

Authors:  S Ohshima KHaraoka; J Suzumiya; C Kawasaki; M Kanda; M Kikuchi
Journal:  Leuk Lymphoma       Date:  2000-08

Review 5.  Angioimmunoblastic-like T-cell non Hodgkin's lymphoma: outcome after chemotherapy in 33 patients and review of the literature.

Authors:  P Pautier; A Devidas; A Delmer; H Dombret; L Sutton; J M Zini; G Nedelec; T Molina; J P Marolleau; P Brice
Journal:  Leuk Lymphoma       Date:  1999-02

6.  Systemic antineutrophil cytoplasmic antibody vasculitis associated with lymphoid neoplasia.

Authors:  M A Hamidou; D El Kouri; M Audrain; J Y Grolleau
Journal:  Ann Rheum Dis       Date:  2001-03       Impact factor: 19.103

7.  CD69 expression correlates with expression of other markers of Th1 T cell differentiation in peripheral T cell lymphomas.

Authors:  David M Dorfman; Aliakbar Shahsafaei
Journal:  Hum Pathol       Date:  2002-03       Impact factor: 3.466

8.  Clinical, biologic, and pathologic features in 157 patients with angioimmunoblastic T-cell lymphoma treated within the Groupe d'Etude des Lymphomes de l'Adulte (GELA) trials.

Authors:  Nathalie Mourad; Nicolas Mounier; Josette Brière; Emmanuel Raffoux; Alain Delmer; Alfred Feller; Chris J L M Meijer; Jean-François Emile; Réda Bouabdallah; André Bosly; Jacques Diebold; Corinne Haioun; Bertrand Coiffier; Christian Gisselbrecht; Philippe Gaulard
Journal:  Blood       Date:  2008-02-21       Impact factor: 22.113

9.  Cutaneous manifestations of angioimmunoblastic lymphadenopathy.

Authors:  J R Seehafer; N C Goldberg; C H Dicken; W P Su
Journal:  Arch Dermatol       Date:  1980-01

Review 10.  Angioimmunoblastic T cell lymphoma: pathobiological insights and clinical implications.

Authors:  Kieron Dunleavy; Wyndham H Wilson; Elaine S Jaffe
Journal:  Curr Opin Hematol       Date:  2007-07       Impact factor: 3.284
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.